Related Experiment Videos
[Case report of Fox-Fordyce disease]
M Löttge1, K Flache, C Schrader
1Poliklinik, Bezirkskrankenhauses, Magdeburg.
Zentralblatt Fur Gynakologie
|January 1, 1988
Summary
A rare case of Morbus Fox-Fordyce occurred in a patient using hormonal contraceptives. Treatment with Norethisterone led to a full recovery, indicating a potential therapeutic option for this condition.
Area of Science:
- Dermatology
- Endocrinology
Background:
- Morbus Fox-Fordyce is a rare skin condition affecting apocrine sweat glands.
- Hormonal contraceptives have been anecdotally linked to various dermatological conditions.
Observation:
- A patient using the hormonal contraceptive pill Trisiston presented with symptoms suggestive of Morbus Fox-Fordyce.
- Differential diagnoses were excluded through thorough histological examination.
Findings:
- The patient was diagnosed with Morbus Fox-Fordyce.
- Treatment with Norethisterone resulted in complete resolution of symptoms within six months.
Implications:
- This case suggests Norethisterone may be an effective treatment for Morbus Fox-Fordyce, particularly in patients using hormonal contraceptives.
- Further research is warranted to explore the efficacy and mechanism of Norethisterone in managing Morbus Fox-Fordyce.